$2.44T
Total marketcap
$76.74B
Total volume
BTC 50.63%     ETH 14.88%
Dominance

GeneLink GNLKQ Stock

0 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
3.98K USD
LOW - HIGH [24H]
0.0000 - 0.0000 USD
VOLUME [24H]
185 USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

GeneLink Price Chart

GeneLink GNLKQ Financial and Trading Overview

GeneLink stock price 0.0000 USD
Previous Close 1.0E-6 USD
Open 1.0E-6 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 1.0E-6 - 1.0E-6 USD
52 Week Range 1.0E-6 - 0.0001 USD
Volume 1.2K USD
Avg. Volume 0 USD
Market Cap 3.98K USD
Beta (5Y Monthly) -141.16338
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

GNLKQ Valuation Measures

Enterprise Value 1.06M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.002517354
Price/Book (mrq) N/A
Enterprise Value/Revenue 0.673
Enterprise Value/EBITDA -0.505

Trading Information

GeneLink Stock Price History

Beta (5Y Monthly) -141.16338
52-Week Change 0%
S&P500 52-Week Change 20.43%
52 Week High 0.0001 USD
52 Week Low 1.0E-6 USD
50-Day Moving Average 0.0001 USD
200-Day Moving Average 0.0001 USD

GNLKQ Share Statistics

Avg. Volume (3 month) 0 USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding 265.02M
Float N/A
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2012
Most Recent Quarter (mrq) September 30, 2013
Next Fiscal Year End December 31, 2013

Profitability

Profit Margin -141.050%
Operating Margin (ttm) -139.46%
Gross Margin 19.40%
EBITDA Margin -133.36%

Management Effectiveness

Return on Assets (ttm) -69.12%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 1.58M USD
Revenue Per Share (ttm) 0.006 USD
Quarterly Revenue Growth (yoy) -30.69%
Gross Profit (ttm) 464.68K USD
EBITDA -2105842 USD
Net Income Avi to Common (ttm) -2227257 USD
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 127.56K USD
Total Cash Per Share (mrq) 0 USD
Total Debt (mrq) 1.19M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.344
Book Value Per Share (mrq) -0.012

Cash Flow Statement

Operating Cash Flow (ttm) -1131392 USD
Levered Free Cash Flow (ttm) -1752195 USD

Profile of GeneLink

Country United States
State FL
City Orlando
Address 8240 Exchange Drive
ZIP 32809
Phone 407-680-1150
Website https://www.genelinkbio.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees N/A

GeneLink, Inc. offers 12-gene DNA assessment services. The company also provides health custom supplements. In addition, it formulates a line of skin care products. The company was founded in 1994 and is based in Orlando, Florida.

Q&A For GeneLink Stock

What is a current GNLKQ stock price?

GeneLink GNLKQ stock price today per share is 0.0000 USD.

How to purchase GeneLink stock?

You can buy GNLKQ shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for GeneLink?

The stock symbol or ticker of GeneLink is GNLKQ.

Which industry does the GeneLink company belong to?

The GeneLink industry is Biotechnology.

How many shares does GeneLink have in circulation?

The max supply of GeneLink shares is 0.

What is GeneLink Price to Earnings Ratio (PE Ratio)?

GeneLink PE Ratio is now.

What was GeneLink earnings per share over the trailing 12 months (TTM)?

GeneLink EPS is 0 USD over the trailing 12 months.

Which sector does the GeneLink company belong to?

The GeneLink sector is Healthcare.